PL369552A1 - Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions - Google Patents

Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions

Info

Publication number
PL369552A1
PL369552A1 PL369552A PL36955204A PL369552A1 PL 369552 A1 PL369552 A1 PL 369552A1 PL 369552 A PL369552 A PL 369552A PL 36955204 A PL36955204 A PL 36955204A PL 369552 A1 PL369552 A1 PL 369552A1
Authority
PL
Poland
Prior art keywords
nutrient
pharmaceutical
laboratory preparation
functioning
functions
Prior art date
Application number
PL369552A
Other languages
Polish (pl)
Inventor
Martyna Kandefer-Szerszeń
Wojciech Rzeski
Barbara Zdzisińska
Stefan Pierzynowski
Original Assignee
Sgp & Sons Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sgp & Sons Ab filed Critical Sgp & Sons Ab
Priority to PL369552A priority Critical patent/PL369552A1/en
Priority to PCT/PL2005/000051 priority patent/WO2006016828A2/en
Publication of PL369552A1 publication Critical patent/PL369552A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL369552A 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions PL369552A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL369552A PL369552A1 (en) 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions
PCT/PL2005/000051 WO2006016828A2 (en) 2004-08-12 2005-08-11 Use of alpha ketoglutarate for treating alzheimer, parkinson

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL369552A PL369552A1 (en) 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions

Publications (1)

Publication Number Publication Date
PL369552A1 true PL369552A1 (en) 2006-02-20

Family

ID=35462217

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369552A PL369552A1 (en) 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions

Country Status (2)

Country Link
PL (1) PL369552A1 (en)
WO (1) WO2006016828A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR080219A1 (en) 2010-02-18 2012-03-21 Osiris Therapeutics Inc IMMUNOCOMPATIBLE CORIONIC MEMBRANE PRODUCTS
AU2013318686B2 (en) 2012-09-19 2017-11-30 Grespo Ab Compositions for improvement of brain function
WO2014116985A1 (en) * 2013-01-25 2014-07-31 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
US20200253907A1 (en) * 2017-08-21 2020-08-13 The Regents Of The University Of California Compositions and Methods for Treating Neurodegenerative Diseases
CN117530940A (en) * 2023-10-11 2024-02-09 四川大学华西第二医院 Application of alpha-ketoglutarate in preparation of medicines for promoting myelin repair and improving neuroinflammation
CN118903086A (en) * 2024-07-16 2024-11-08 贵州医科大学 Application of alpha-ketoglutarate nano-particles in preparation of preparation for treating parkinsonism

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402027D0 (en) * 1994-06-10 1994-06-10 Pharmacia Ab Energy substrates
AU760140B2 (en) * 1997-10-24 2003-05-08 John P. Blass Nutritional supplement for cerebral metabolic insufficiencies
DE19755367C2 (en) * 1997-12-12 2001-03-22 Afting Ernst Guenter Pharmaceutical composition containing D-galactose and its use
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
US20020193335A1 (en) * 2001-03-02 2002-12-19 Hesson David P. Gene therapy for neurological tissues
FR2822704B1 (en) * 2001-03-29 2005-02-18 Chiesi Sa SALTS OF KETOACIDES AND GASTRORESISTANT AMINO ACIDS AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS
NZ530554A (en) * 2004-01-13 2004-04-30 A Neuronutrients

Also Published As

Publication number Publication date
WO2006016828A2 (en) 2006-02-16
WO2006016828A8 (en) 2007-07-19
WO2006016828A3 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
WO2008080134A3 (en) 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
EP2476679A3 (en) Substituted triazoles useful as AXL inhibitors
TWI320316B (en) Methods for inhibiting hscd activity,pyridazine derivatives and use and pharmaceutical composition thereof
IL182876A0 (en) Lactam compounds and their use as pharmaceuticals
WO2007022245A3 (en) Patient compliance system and method to promote patient compliance
IL183583A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
WO2008083367A3 (en) Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL186458A0 (en) Skin enrichment using coq10 as the delivery system
WO2007030680A3 (en) Triazole derivatives useful as axl inhibitors
EP2484679A3 (en) N3-heteroaryl substituted triazoles and n5-heteroaryl substitued triazoles useful as axl inhibitors
GB0409806D0 (en) Nerve blocking method and system
ZA200802167B (en) Compounds which have activity at M1 Receptor and their uses in medicine
IL187235A0 (en) 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
IL182054A0 (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
PL1720544T3 (en) Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
IL177073A (en) Hydroxy-6-heteroarylphenanthridine derivatives and pharmaceutical compositions containing the same
IL179253A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
SI1835022T1 (en) Cell culture method and utilization of the same
IL188848A (en) Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)